Modulation of T cell responses with MHC-derived peptides

Area of Science:

• Immunology
• Molecular Biology
• T cell receptor (TCR) interactions

Background:

• T cell activation relies on T cell receptors (TCRs) binding peptide-MHC complexes.
• The helical regions within MHC molecules are thought to provide TCR contact residues.
• Investigating peptides from these helical regions could reveal new immune modulation strategies.

Purpose of the Study:

• To investigate the immunomodulatory potential of a peptide derived from the IAk beta 1 domain (IAk 68-83).
• To determine if this peptide interacts directly with T cell receptors (TCRs).
• To assess the peptide's ability to modulate T cell activation and recognition.

Main Methods:

• Synthesized a peptide (IAk 68-83) from a predicted helical region of the IAk molecule.
• Tested the peptide's binding to anti-IAk antibodies and its inhibition of antibody binding to cells.
• Assessed the peptide's effect on antigen-dependent T cell activation (clone D10.G4).
• Utilized BSA-peptide conjugates for cell staining and competition assays.

Main Results:

• The IAk 68-83 peptide bound to an anti-IAk antibody, inhibiting its cellular binding.
• The peptide inhibited antigen-specific activation of the D10.G4 T cell clone.
• BSA-conjugated peptide specifically stained D10.G4 cells, indicating TCR interaction.
• Competition assays confirmed the specificity of the peptide-TCR interaction.

Conclusions:

• Peptides derived from MHC class II helical regions can interact directly with TCRs.
• These peptides hold potential for modulating immune responses.
• Further research into these peptides could lead to novel immunotherapeutic strategies.